Trial
NCT02401035
PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Gastroesophageal Reflux Disease
Intervention
IV pantoprazole
Why stopped
Study was terminated early due to the infeasibility of enrolling the required number of participants per protocol in the 1 \<2 years of age cohort.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-09